NEW YORK, April 28, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Digital Pathology: Technologies and Global Markets
The global digital pathology market totaled nearly $2.1 billion in 2012. This market is expected to grow at a compound annual growth rate (CAGR) of 14.7% from $2.2 billion in 2013 to nearly $4.5 billion in 2018.
This report provides:
An overview of the global digital pathology market.
Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
Information on key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence, and geographic trends.
Discussion on various supply chain members such as manufacturers, suppliers, service providers and diagnostic centres.
STUDY AND OBJECTIVE
Objectives of this study report include:
To define and identify the structure for the global digital pathology market and discuss key market issues.
To measure and estimate the global digital pathology market and its segments for products, end users and key applications for the period from 2013 to 2018.
To identify opportunities and major factors driving and inhibiting growth of the global labware market and its subsegments.
To identify and analyze key market issues, trends, gaps and opportunities in each of the micro-markets.
To intensively study the key factors that impact market growth by subsegments and geography and to analyze trends and opportunities in major regions, including North America, Europe, Asia and the rest of the world (ROW).
To identify key companies, product portfolios, strategies and recent developments.
To assess key competitive scenarios, top strategies and segments of key companies.
To present key conclusions conducted through intensive primary and secondary research.
The role of a conventional laboratory is to focus on cost savings, increased laboratory workload and innovative technologies, such as m-health. Digital pathology and telepathology are seen as effective solutions with significant scopes to address the prevailing issues of cost, time and technology. Digital pathology and telepathology offer improved connectivity and reduce healthcare costs. Successful and consistent adoption of digital pathology and telepathology in developed economies is encouraging the developing economies to experiment as well.The creation of disciplined regulatory environments that protect patient safety and focus on electronic medical records (EMRs), the need for quick diagnoses and the maintenance of cost issues will drive the market. The evolving market, however, presents significant challenges, including significant deployment costs, U.S. Food and Drug Administration (FDA) approvals, technological complexities, and a lack of skilled staff and conventional pathologists.The scenario is very different in developing economies, where the concepts of telepathology and digital pathology are so far relevant only to niche and reputed laboratories. There are significant complexities involved in the process of enabling the adoption of novel technologies. Technology providers are having difficulty meeting varied customer expectations in different regions with respect to the products or services they offer, price and quality. This requires a deeper understanding of the existing infrastructure and process, cost-versus-value expectations, regulatory issues and other driving forces. This report addresses these issues and provides a comprehensive and objective study to enhance the market presence of participants such as digital pathology technology providers, product manufacturers, service providers, system integrators and other key value chain members.
SCOPE OF THE REPORT
This report includes forecasted trends and sales in the digital pathology and telepathology markets through 2018. Key market participants, extensive product segments, supporting technologies, trends and market dynamics, competitive intelligence and regional trends are discussed. There is a detailed discussion on market dynamics and the level of impact, key geographies and respective trends and competitive scenarios that will form the base data for qualitative analysis and market estimates.The digital pathology and telepathology market has been analyzed for the four main geographic regions: North America, Europe, Asia and the rest of the world (ROW).The report will provide details with respect to the conventional process of pathology laboratories, but it will specifically exclude the scope of market analysis for conventional path-lab devices (e.g., conventional microscopes, slides). The connectivity and network issues discussed in the report will be specific to data and information generated from pathology labs and that regarding specific diagnosis, but it will exclude general hospital-based m-health issues. Telepathology covered in the report is limited to diagnostic, research and development (R&D), and education and training applications. It excludes the scope of telemedicine at a larger level.
The intended audience for this report includes:
Digital pathology component manufacturers and potential entrants.
Manufacturers of digital in vitro diagnostic (IVD) devices and potential entrants.
Key software companies involved in delivering storage, analytics and communication platforms for digital pathology systems.
Dealers, distributors and service providers of digital lab equipment and devices.
Pharmaceutical and other life science companies.
Research institutes, associations and academics.
SOURCE OF INFORMATION AND METHODOLOGY
A top-down approach was used to estimate the market sizes of labware products and applications. The research methodology used to calculate market size also includes:
Market revenues of the key players were determined through primary and secondary research, including a study of annual reports of top market players and interviews with key opinion leaders such as chief executive officers (CEOs) and directors.
Secondary research included a general search by keywords through paid sources such as Factiva and One Source, as well as other publicly available websites and company websites.
The penetration of micromarkets was established through primary and secondary sources and validated through primary sources.
The forecast was based on analysis of market trends such as pricing and volume analysis.
The geographic split was determined by using secondary sources verified through primary sources.
The geographic split was based on various parameters such as the number of players in a particular region, the extent of research activity occurring in that region and future potential (e.g., the scope for increase in number of laboratories).
Chapter- 1: INTRODUCTION
STUDY AND OBJECTIVE
SCOPE OF THE REPORT
SOURCE OF INFORMATION AND METHODOLOGY
RELATED BCC RESEARCH REPORTS
BCC RESEARCH ONLINE SERVICES
Chapter- 2: EXECUTIVE SUMMARY
Table Summary : GLOBAL DIGITAL PATHOLOGY MARKET BY REGION, THROUGH 2018
Figure Summary : GLOBAL DIGITAL PATHOLOGY MARKET BY REGION, 2012-2018
Chapter- 3: MARKET OVERVIEW
TELEPATHOLOGY AND DIGITAL PATHOLOGY: MARKET DEFINITION, EVOLUTION AND INTEGRATION
CONVENTIONAL PROCESS VERSUS DIGITAL PATHOLOGY AND COST WORKS
IMAGE ANALYSIS AND ITS IMPORTANCE IN KEY RESEARCH AREAS
DIGITAL PATHOLOGY IN CLINICAL TRIALS
DIGITAL PATHOLOGY: ELECTRONIC HEALTH RECORDS, ELECTRONIC MEDICAL RECORDS AND OTHER INFORMATION SYSTEMS
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT
DIGITAL PATHOLOGY: DEVELOPED VERSUS DEVELOPING ECONOMIES
TECHNOLOGY TRANSITION: DIGITAL PATHOLOGY COMPONENTS TO INTEGRATED SYSTEMS
AGREEMENTS AND COLLABORATIONS TO ENHANCE PRESENCE IN IMAGING APPLICATIONS
U.S. AS THE BASE FOR DIGITAL PATHOLOGY SYSTEM INNOVATION
Chapter- 4: DIGITAL PATHOLOGY SYSTEM MARKET
DIGITAL PATHOLOGY ANALYTIC MARKET
DIGITAL PATHOLOGY STORAGE AND COMMUNICATION PLATFORM MARKET
Table 1 : GLOBAL DIGITAL PATHOLOGY SYSTEM MARKET, THROUGH 2018
Chapter- 5: IN VITRO DIAGNOSTIC AND OTHER DIAGNOSTIC DEVICES IN DIGITAL PATHOLOGY MARKET
AUTOMATED HEMATOLOGY ANALYZERS AND BLOOD CELL COUNTERS
DIGITAL CHROMOSOME ANALYZERS
FLUORESCENCE IN SITU HYBRIDIZATION ENUMERATION SYSTEMS
DIGITAL URINE SEDIMENT ANALYZERS
IMMUNOHISTOCHEMISTRY IMAGE ANALYSIS APPLICATIONS
DIGITAL POLYMERASE CHAIN REACTION
SIGNET CELL DETECTION
DIGITAL HOLOGRAPHIC MICROSCOPY
Table 19 : GLOBAL DIGITAL IN VITRO AND OTHER DIAGNOSTIC DEVICE MARKET, THROUGH 2018
Table 20 : GLOBAL DIGITAL IN VITRO AND OTHER DIAGNOSTIC DEVICES MARKET BY REGION, THROUGH 2018
Chapter- 6: PATHOLOGY MARKET TYPES
HEMATOLOGY AND CLINICAL PATHOLOGY
Table 30 : GLOBAL DIGITAL PATHOLOGY MARKET BY TYPE, THROUGH 2018
Chapter- 7: DIGITAL PATHOLOGY APPLICATION MARKET
DRUG DISCOVERY AND DRUG DEVELOPMENT
RESEARCH AND DEVELOPMENT
Table 38 : GLOBAL DIGITAL PATHOLOGY MARKET BY APPLICATION, THROUGH 2018
Chapter- 8: END-USER MARKET
BIOTECH AND PHARMA COMPANIES
HOSPITALS AND DIAGNOSTIC CENTERS
ACADEMIC CENTERS: CONSULTING AND TRAINING
Table 42 : GLOBAL DIGITAL PATHOLOGY MARKET BY END USER, THROUGH 2018
Chapter- 9: COMPETITIVE LANDSCAPE
NEW PRODUCT DEVELOPMENT
AGREEMENTS AND COLLABORATIONS
MERGERS AND ACQUISITIONS
Chapter- 10: GEOGRAPHIC ANALYSIS
REST OF THE WORLD
Chapter- 11: PATENT ANALYSIS
U.S. PATENT ANALYSIS
EUROPEAN PATENT ANALYSIS
JAPAN PATENT ANALYSIS
Chapter- 12: COMPANY PROFILES
APERIO TECHNOLOGIES INC.
APOLLO PACS INC.
AURORA INTERACTIVE LTD.
HURON TECHNOLOGIES INTERNATIONAL INC.
INDICA LABS INC.
LEICA MICROSYSTEMS GMBH
MIKROSCAN TECHNOLOGIES INC.
NIKON INSTRUMENTS INC.
SUNQUEST INFORMATION SYSTEMS
VENTANA MEDICAL SYSTEMS INC.
Chapter- 13: APPENDIX
To order this report: Digital Pathology: Technologies and Global Markets
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001